Latest Articles
Incyte’s POD1UM-204 Endometrial Cancer Study Wraps Up, Setting the Stage for Key Retifanlimab Data - TipRanks
Incyte’s POD1UM-204 Endometrial Cancer Study Wraps Up, Setting the Stage for Key Retifanlimab Data TipRanks
Published: June 11, 2026, 4:35 p.m.
Bulletin: GLP-1RAs Help Reduce Obesity Related Cancers - Medical News Bulletin
Bulletin: GLP-1RAs Help Reduce Obesity Related Cancers Medical News Bulletin
Published: June 11, 2026, 2:44 p.m.
GLP-1 RAs Help Reduce Obesity Related Cancers - Medical News Bulletin
GLP-1 RAs Help Reduce Obesity Related Cancers Medical News Bulletin
Published: June 11, 2026, 2:37 p.m.
Roche's VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies - The Malaysian Reserve
Roche's VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies The Malaysian Reserve
Published: June 11, 2026, 6:33 a.m.
Roche's VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies - StreetInsider
Roche's VENTANA MMR RxDx Panel companion diagnostic receives IVDR approval across multiple cancer types and therapies StreetInsider
Published: June 11, 2026, 5:42 a.m.
p16 Beyond Senescence: Cancer Biology Lessons Applied to Endometriosis.
Endometriosis is an estrogen-dependent disease characterized by chronic inflammation and fibrosis and is a major cause of pelvic pain and infertility. Recent studies have reported dysregulated expression of p16INK4a, a …
Published: June 11, 2026, midnight
Deep infiltrating endometriosis presenting as acute abdomen with extremely elevated tumor markers: a cancer-mimicking case.
Deep infiltrating endometriosis (DIE) is a rare and severe subtype of endometriosis that can cause marked distortion of pelvic anatomy. Diagnosis becomes particularly challenging when it presents as an acute …
Published: June 11, 2026, midnight
Breast cancer and endometriosis drug Zoladex is being pulled from Australia. How will women be affected? - The Guardian
Breast cancer and endometriosis drug Zoladex is being pulled from Australia. How will women be affected? The Guardian
Published: June 10, 2026, 9:17 p.m.
Four-Year RUBY Data Support Curative Intent With Dostarlimab in dMMR/MSI-H Endometrial Cancer - The ASCO Post
Four-Year RUBY Data Support Curative Intent With Dostarlimab in dMMR/MSI-H Endometrial Cancer The ASCO Post
Published: June 10, 2026, 4:41 p.m.
“I Dismissed It as Menopause”—One Woman’s Endometrial Cancer Story - Chatelaine
“I Dismissed It as Menopause”—One Woman’s Endometrial Cancer Story Chatelaine
Published: June 9, 2026, 7:04 p.m.
Link copied to clipboard!